Sign in
SNTI Stock Price, Chart, Stats & News
Senti Biosciences, Inc.
Save
Senti Biosciences, Inc. (SNTI) does not currently pay a dividend.
9.65M
Market cap
–
Current P/E
–
Forward P/E
SNTI chart
Fundamentals
Gross margin | -14777.27% |
Operating margin | -289668.18% |
Pretax margin | -279263.64% |
Net margin | -279263.64% |
Effective tax rate | – |
ROA | -119.94% |
ROE | -322.42% |
D/E | 5.17x |
Interest coverage ratio | – |
SNTI valuation
P/E | – |
P/S | 944.20x |
P/B | 3.18x |
P/CF | -0.41x |
P/FCF | -0.48x |
P/OCF | -0.41x |
PEG | 0.03x |
EV multiple | -0.14x |
About
Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells. This allows the modified cells to interpret biological cues, make precise decisions, and react appropriately within their specific cellular surroundings.
Similar securities
Based on sector and market capitalization
Report issue